| SEC FILE NUMBER | |
| 001-13101 | |
| CUSIP NUMBER | |
| Common Stock: 00175J107 | |
| Preferred Stock: 00175J206 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
| (Check One): | ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR | |
| For Period Ended: December 31, 2024 | ||
| ☐ Transition Report on Form 10-K | ||
| ☐ Transition Report on Form 20-F | ||
| ☐ Transition Report on Form 11-K | ||
| ☐ Transition Report on Form 10-Q | ||
| For the Transition Period Ended: | ||
| Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein. |
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: Not Applicable.
PART I — REGISTRANT INFORMATION
AMMO, INC.
Full Name of Registrant
N/A
Former Name if Applicable
7681 E. Gray Rd.
Address of Principal Executive Office (Street and Number)
Scottsdale, Arizona 85260
City, State and Zip Code
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
| ☐ | (a) | The reasons described in reasonable detail in Part III of this Form could not be eliminated without unreasonable effort or expense;
| |
| (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
| ||
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
This Form 12b-25 (Notification of Late Filing) is filed by Ammo, Inc. (the “Company”) with respect to its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024 (the “Quarterly Report”) pursuant to Rule 12b-25 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
As previously disclosed, the Company’s previously reported financial statements for certain historical periods should no longer be relied upon. Specifically, the Company’s financial statements as of and for the years ended March 31, 2024, 2023, 2022 and 2021, as well as all interim periods within such years (collectively, the “Affected Periods”), including the auditors’ reports on the financial statements for all fiscal years within the Affected Periods and the auditors’ report on internal controls for the years ended March 31, 2024 and 2023, should no longer be relied upon. Also, as previously disclosed, a Special Committee of the Board of Directors of the Company (the “Board”) retained a law firm to conduct an independent investigation (the “Investigation”) focused on fiscal years 2020 through 2023. The scope of the Investigation includes, among other things, an assessment of whether the Company and its management control persons at the time (i) accurately disclosed all executive officers, members of management, and potential related party transactions in fiscal years 2020 through 2023, (ii) properly characterized certain fees paid for investor relations and legal services as reductions of proceeds from capital raises rather than period expenses in fiscal years 2021 and 2022 and (iii) appropriately valued unrestricted stock awards to officers, directors, employees and others in fiscal years 2020 through 2023 (collectively, the “Investigation Issues”). Furthermore, as previously disclosed, the Company’s management concluded that in light of the Investigation Issues, a material weakness existed in the Company’s internal control over financial reporting during the Affected Periods and that the Company’s disclosure controls and procedures were not effective. To address this material weakness, management has devoted, and plans to continue to devote, significant effort and resources to the remediation and improvement of Company’s internal control over financial reporting. Specifically, the Company is, among other things, identifying deficiency exposure, evaluating its control environment, testing operating effectiveness, assessing tests of design, addressing segregation of duties, evaluating management review controls and procedures, and developing and implementing remediation plans.
On February 4, 2025, the Audit Committee of the Board, in consultation with the Company’s management, determined that the Company’s financial statements for the Affected Periods will be restated. The Company intends to restate the financial statements relating to the Affected Periods as soon as reasonably practicable following the conclusion of the Investigation. The Audit Committee of the Board, in consultation with the Company’s management, is continuing to assess whether it may be necessary to restate the Company’s financial statements for other periods, including periods prior to fiscal year 2021.
The Company’s current management team is committed to remediating the material weakness, addressing the Investigation Issues, restating the financial statements for the Affected Periods in a timely manner, and promoting a culture of transparency and open communication within the Company. Nonetheless, the Company has determined that it is unable to file the Quarterly Report by the prescribed due date without unreasonable effort or expense because the Investigation is still ongoing. While the Company intends to file the Quarterly Report as soon as practicable, it does not expect to file the Quarterly Report within the five-day extension period provided by Rule 12b-25 under the Exchange Act. Counsel for the Special Committee of the Board intends and expects to complete the Investigation in the near future.
Cautionary Note Regarding Forward-Looking Statements
This Form 12b-25 contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. These forward-looking statements include statements regarding the expected timing of the filing of the Quarterly Report, the timing of the completion of the Investigation, the timing for restating the financial statements for the Affected Periods, and the Company’s ability to effectively remediate material weaknesses relating to internal controls over financial reporting. Forward-looking statements include all statements that are not solely historical facts and can be identified by terms such as “believe,” “anticipate,” “could,” “estimate,” “expect,” “may,” “will,” “should,” or similar expressions. Investors are cautioned not to place undue reliance on these forward-looking statements, which are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, including the risks and uncertainties addressed under the heading “Risk Factors” and elsewhere in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, and the other filings the Company makes with the Commission from time to time. These forward-looking statements speak only as of the date of this Form 12b-25, and the Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances occurring after the date hereof.
PART IV — OTHER INFORMATION
| (1) | Name and telephone number of person to contact in regard to this notification: | ||||
| Jordan Christensen | (480) | 947-0001 | |||
| (Name) | (Area code) | (Telephone Number) | |||
| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes ☐ No | ||||
| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes ☐ No | ||||
| If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. | |||||
Given that the Investigation is ongoing and the financial statements for the Affected Periods should no longer be relied upon, the Company is unable to make a reasonable estimate of any changes in results of operations in its financial statements until after the Investigation is complete. For additional information, see the discussion above in Part III.
AMMO, INC.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: February 10, 2025 | By: | /s/ Jared R. Smith |
| Jared R. Smith | ||
| Chief Executive Officer |